Qiliqiangxin Alleviates Imbalance of Inflammatory Cytokines in Patients with Dilated Cardiomyopathy: A Randomized Controlled Trial
This study demonstrates that #Qiliqiangxin may rebalance #Inflammatory #Cytokines in patients with #DilatedCardiomyopathy, and that combining it with standard anti-#HeartFailure medications could further improve #CardiacFunction. #medsky
To read: doi.org/10.1007/s115...